Search Results

Search Results

No Results Found

Try adjusting your search to find what you’re looking for.

US-based clinical stage Cell Therapy company focused on allogeneic platform needed to secure supply for Yssel’s T-Cell media to confidently meet their manufacturing scale up following positive results from their clinical development process.

Gene Therapy:  Scaling from lab to cGMP

US-based, pre-clinical stage Gene Therapy innovator scaling products from benchtop to pilot required a nimble liquid manufacturing partner to rapidly manufacture and adjust buffers for process optimization.

Research: Lab requires AOF components

Southern US-based cell therapy research lab, located at world renowned cancer research institution, investigating the use of genetically modified CAR NK cells was experiencing inconsistent cell biological activity due to IL-2.
Southeast Asian clinical stage Cell Therapy company focused on allogeneic cell therapies required custom aliquots of media components, including human serum, cytokines, growth factors, and other components in single use containment bags to simplify their workflow.
Middle Eastern-based, clinical stage Cell Therapy company needed to reduce risk and potential concerns from the US FDA regarding cell culture products with animal components.